Global X ETFs
Arelis Agosto currently serves as the VP and Director of Research & Strategy at Global X ETFs, a position held since January 2022, where leadership of research initiatives across thematic, options, income, and commodities is a primary focus. Prior to this role, Arelis Agosto worked at Third Bridge Group Limited from October 2018 to December 2021, first as an AVP and then as a Senior Healthcare Analyst, specializing in coverage areas such as US pharmaceuticals, biotechnology, life sciences, diagnostics, pharmaceutical services, and animal health across various asset classes. Arelis Agosto also gained experience at Clarkston Consulting as a Healthcare Analyst and Management Consulting Intern in 2017, along with a student consultancy role earlier in the same organization. Arelis Agosto holds a Bachelor's degree in Business with a concentration in Global Business Management from Babson College, completed in 2018.
This person is not in the org chart
This person is not in any offices
Global X ETFs
Global X ETFs was founded in 2008. For more than a decade, our mission has been empowering investors with unexplored and intelligent solutions. Our product lineup features more than 90 ETFs, spanning disruptive technology, equity income, commodities, hard-to-access emerging markets, and more. Or simply put, we strive to offer investors something beyond ordinary. Global X is a member of Mirae Asset Global Investments, a Seoul-based global enterprise which offers asset management expertise worldwide. Explore our ETFs, research and insights, and more at globalxetfs.com Important disclosures: globalxetfs.com/privacy Global X ETFs is a trade name of Global X Management Company LLC and is not to be confused with Global X Funds, which is a separate legal entity with no employees.
Employees
51-200